Thermo Fisher Scientific Inc. (LON:0R0H)
483.78
+0.12 (0.02%)
At close: Aug 14, 2025
Thermo Fisher Scientific Revenue
Thermo Fisher Scientific had revenue of $10.86B USD in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
4.32
Revenue / Employee
$345.70K
Employees
125,000
Market Cap
136.10B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
Oxford Nanopore Technologies | 183.19M |
HUTCHMED (China) | 439.54M |
Thermo Fisher Scientific News
- 14 days ago - Trade tracker: Bill Baruch buys Thermo Fisher - CNBC
- 17 days ago - Thermo Fisher Posts 3% Q2 Rise - The Motley Fool
- 17 days ago - Unpacking the Latest Options Trading Trends in Thermo Fisher Scientific - Benzinga
- 18 days ago - Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - Business Wire
- 19 days ago - Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
- 19 days ago - Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus - Seeking Alpha
- 22 days ago - Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - Business Wire
- 23 days ago - Thermo Fisher Posts 3% Q2 Revenue Gain - The Motley Fool